PMID-sentid	Pub_year	Sent_text		comp_official_name	comp_offsetprotein_name	organism	prot_offset
34058070-9	2021	Finally, a c-MYC gain, along with a loss of CCND1 and FGFR3, were detected in a patient progressing on a first-line treatment with crizotinib.	Crizotinib	131-141	fibroblast growth factor receptor 3	Homo sapiens	54-59